Advanced Micro Devices, Inc.

The Home Depot, Inc.

International Business Machines Corporation

Major US stock market indices jumped on Tuesday, February 24, after investors reassessed the negative impact of AI on global business processes. A presentation by AI startup Anthropic showed that its tools will not replace software developers, but will strengthen them by enabling them to develop products using their AI Claude. That calmed the markets a bit and the Software Developers Sector ETF rose 2% after several days of declines.

U.S. stocks are up. Why have fears of a soft-apocalypse abated?

Blue Owl Capital Inc.

Blue Owl Capital Corporation

JPMorgan Chase & Co.

The head of the largest US bank JPMorgan Jamie Dimon said he sees signs in the financial market reminiscent of the situation before the 2008 crisis. He warned of risks in lending amid aggressive competition and weakening standards. Fears that a <a href="https://oninvest.com/article/kanarejka-v-sahte-dla-finsektora-cto-znacit-blokirovka-deneg-v-blue-owl-dla-rynka">bubble is inflating</a> in private lending are increasingly worrying investors.

"The market is doing stupid things": the head of JPMorgan saw signs of a crisis on the scale of 2008

Novo Nordisk A/S

Eli Lilly and Company

Danish company Novo Nordisk <a href="https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916504">has announced</a> its intention to reduce list prices in the US for its flagship weight loss and diabetes drugs Wegovy and Ozempic. Their prices will be reduced by up to 50% starting next year, according to the company. Novo said it expects to increase the affordability of the therapy in this way, especially for those who pay for the treatment themselves - partially or fully.

Novo Nordisk to cut prices on weight loss products by up to 50%. Why is the stock falling?

Spotify Technology S.A.

Salesforce, Inc.

Alphabet Inc.

Microsoft Corporation

AI startup Anthropic <a href="https://www.youtube.com/watch?v=YZVpUeEvGxs">unveiled</a> on Feb. 24 new ways to integrate its AI agents into enterprise operations - Anthropic's new AI plug-ins enterprises can use to "turbo-accelerate" the capabilities of individual office workers, CNBC <a href="https://www.cnbc.com/2026/02/24/anthropic-claude-cowork-office-worker.html">writes.</a>

Anthropic unveiled updated AI tools for "turbo acceleration". What's on the market?

Pavel Durov, the founder of Telegram, has reacted to the information that a criminal case has been opened against him in Russia on charges of "promoting terrorism."

"A sad sight": Telegram founder reacted to criminal case in Russia 

York Space Systems, Inc.

Eight Wall Street analysts at one time <a href="https://www.marketwatch.com/investing/stock/yss/analystestimates?mod=mw_quote_tab">recommended</a> buying shares of low-cost satellite maker York Space Systems, which <a href="https://ir.yorkspacesystems.com/news/news-details/2026/York-Space-Systems-Announces-Pricing-of-Upsized-Initial-Public-Offering/default.aspx">IPOed</a> on the New York Stock Exchange less than a month ago. The company depends on government funding and projects such as U.S. President Donald Trump's Golden Dome missile defense system, but it's a risk Wall Street thinks <a href="https://www.barrons.com/articles/york-space-systems-stock-ratings-26467d20?mod=RTA">is</a> worth taking, Barron's said.

There were 8 analysts who advised buying a newcomer to the York Space exchange. What attracted them?

NVIDIA Corporation

The company has become the top target for shorts among all S&amp;P 500 participants

'More skepticism than stress': shorts bet $50 billion against Nvidia ahead of report

Bitcoin is approaching its worst monthly performance since June 2022, when the crypto industry experienced a wave of corporate bankruptcies. Back then, the collapse of the TerraUSD stablecoin project triggered a chain reaction of bankruptcies affecting crypto hedge fund Three Arrows Capital and lender BlockFi, Bloomberg <a href="https://www.bloomberg.com/news/articles/2026-02-24/bitcoin-btc-heads-for-worst-month-since-june-2022-crypto-winter">writes</a>. On February 24, bitcoin fell 2.64% to $62,858. In February, the cryptocurrency has already lost 19%.

February could be the worst February for bitcoin since the 2022 cryptocrisis

Data

Arcellx, Inc.

Gilead Sciences, Inc.

Shares of Arcellx, a mid-cap developer of cell therapy for blood cancer, <a href="https://finance.yahoo.com/quote/ACLX/">soared</a> 77% on February 23 to a new all-time high. A major partner, Gilead Sciences, <a href="https://ir.arcellx.com/news/news-details/2026/Gilead-Sciences-to-Acquire-Arcellx-to-Maximize-Long-term-Potential-of-Anito-cel/default.aspx">plans to buy the</a> company at a significant premium to its market value. For investors, this is a signal that leading market players increasingly prefer not to cooperate with smaller companies, and fully own assets, <a href="https://www.channelchek.com/news-channel/gilead-to-acquire-arcellx-in-7-8b-bet-on-next-gen-car-t-leadership">said</a> broker Noble Capital Markets.

Developer of a new cancer therapy Arcellx saw its price rise 77% in a day. What's the reason?

Lucid Group, Inc.

Investors should avoid buying shares of electric vehicle maker Lucid in the hope of a rebound, <a href="https://www.fool.com/investing/2026/02/22/should-you-buy-lucid-while-its-below-10/">argues</a>&nbsp;Motley Fool contributor Chris Neiger. Over the past three years, the company’s stock has fallen about 90%, a decline that may make the shares look attractive ahead of the planned launch of a lower-priced EV model. But that appeal is misleading, the analyst believes, the core issue being that Lucid remains deeply unprofitable.

Motley Fool analyst warns against temptation to buy EV maker Lucid on the dip

Hims & Hers Health, Inc.

U.S. telehealth platform and online pharmacy Hims &amp; Hers Health will <a href="https://investors.hims.com/news/news-details/2026/Hims--Hers-Announces-Agreement-to-Acquire-Eucalyptus-Accelerating-Its-Vision-to-Become-the-Leading-Global-Consumer-Health-Platform/default.aspx">acquire</a>&nbsp;Australian peer Eucalyptus. The deal comes as the company <a href="https://finance.yahoo.com/news/hims-hers-1-2-billion-165104901.html">seeks</a>&nbsp;to reshape investor perceptions after U.S. regulators <a href="https://en.oninvest.com/article/novo-shares-rise-cheap-copy-of-its-drug-fails-to-survive-criticism-from-us-regulatorhttps://en.oninvest.com/article/novo-shares-rise-cheap-copy-of-its-drug-fails-to-survive-criticism-from-us-regulatorhttps://en.oninvest.com/article/novo-shares-rise-cheap-copy-of-its-drug-fails-to-survive-criticism-from-us-regulator">criticized</a>&nbsp;it over the sale of a copycat of Novo Nordisk’s obesity drug Wegovy and the Danish drugmaker filed a lawsuit.

Hims & Hers to buy Australian peer Eucalyptus amid GLP-1 regulatory, legal pressure

Peloton Interactive, Inc.

Alvotech

Grab Holdings Limited

Snap Inc.

Aurora Innovation, Inc.

AtaiBeckley Inc.

FuboTV Inc.

Small-cap stocks could benefit from several structural trends in 2026. The segment is expected to be supported by investments in AI infrastructure, as well as localization and upgrades of production facilities, American Century Investments <a href="https://www.americancentury.com/institutional-investors/insights/global-small-caps-trends/">said</a> in a January report. Analysts expect small-cap companies to outpace large-cap peers in earnings per share (EPS) growth in 2026: small-cap EPS is projected to rise 21.8% versus 16.0% for large caps. In 2025, the situation was the opposite, with small-cap EPS up 12.2% versus 13.9% for large caps.

Insider Monkey spotlights 12 best penny stocks set to skyrocket

Recursion Pharmaceuticals, Inc.

ARK Invest, headed by investor Cathie Wood, has increased its stake in small-cap biotech Recursion Pharmaceuticals, which <a href="https://ir.recursion.com/">uses</a>&nbsp;one of the world’s most powerful supercomputers to identify patterns and develop therapies for deadly diseases. The news of Wood's purchase <a href="https://finance.yahoo.com/quote/RXRX/">helped lift</a> the stock more than 5% on Thursday. Earlier, it emerged that chipmaker Nvidia had exited its position in the company.

Cathie Wood increases stake in small-cap biotech Recursion after Nvidia exits

Small Caps

Important news and analysis of global stock markets, plus crypto, bonds, and ETFs

Investment and Finance News